RE: RSP / supply profile26 Nov 2019 15:48
Under the terms of the deal, the lender has agreed to not test the financial covenants associated with its loans until June 30 of next year, at which point it will start again with lower revenue targets.
Tissue Regenix said it will also continue to have access to the revolving credit facility. After the loan repayment, the company said that it will have a cash balance of around $3.7 million.